// App-Quantinova.ai

e17091 : T-LAK cell-originated protein kinase (TOPK) as a prognostic factor and a potential therapeutic target in ovarian cancer.

Researchers

Presenter

  • Yuji Ikeda

Principal Investigators

  • Jae Hyun Park

  • Takashi Miyamoto

  • Naofumi Takamatsu

  • Akiko Iwasa

  • Shuhei Okabe

  • Yuichi Imai

  • Keiichi Fujiwara

  • Yusuke Nakamura

  • Kosei Hasegawa

Medical Centers

  • The University of Chicago Medical Center, Chicago, IL

  • OncoTherapy Science, Inc., Kanagawa, Japan

  • Saitama Medical University International Medical Center, Hidaka, Japan

  • Saitama Medical University International Medical Center, Hidaka, Japan

  • Saitama Medical University International Medical Center, Hidaka, Japan

Locations

  • United States

  • Japan

Companies

  • OncoTherapy Science,

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Ovarian cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • OTS964

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved